Karl Gademann

Karl Gademann

Auto-generated profile, based on publicly available information

Karl Gademann

University of Zürich

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Cell Metabolism
Verified
Journal Article
Closed access
CCCarles Cantó
Carles Cantó
RHRiekelt Houtkooper
Riekelt Houtkooper
EPEija Pirinen
Eija Pirinen
DYDou Y. Youn
Dou Y. Youn
MOMaaike H. Oosterveer
Maaike H. Oosterveer
JAJohan Auwerx
Johan Auwerx

7 September 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MTMasanori Toyofuku
Masanori Toyofuku
GCGerardo Cárcamo-Oyarce
Gerardo Cárcamo-Oyarce
TYTatsuya Yamamoto
Tatsuya Yamamoto
FEFabian Eisenstein
Fabian Eisenstein
CHChien-Chi Hsiao
Chien-Chi Hsiao
LELeo Eberl
Leo Eberl
Bacteria release membrane vesicles (MVs) that play important roles in various biological processes. However, the mechanisms of MV formation in Gram-positive bacteria are unclear, as these cells possess a single cytoplasmic membrane that is surrounded by a thick cell wall. Here we use live cell imaging and electron cryo-tomography to describe a mechanism for MV formation in Bacillus subtilis. We show that the expression of a prophage-encoded endolysin in a sub-population of cells generates holes in the peptidoglycan cell wall. Through these openings, cytoplasmic membrane material protrudes into the extracellular space and is released as MVs. Due to the loss of membrane integrity, the induced cells eventually die. The vesicle-producing cells induce MV formation in neighboring cells by the enzymatic action of the released endolysin. Our results support the idea that endolysins may be important for MV formation in bacteria, and this mechanism may potentially be useful for the production of MVs for applications in biomedicine and nanotechnology.

8 June 2010 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
HJHenning Jessen
Henning Jessen
KGKarl Gademann
Karl Gademann
Covering: 1982 to 2009 4-Hydroxy-2-pyridone alkaloids exert diverse biological effects, ranging from antifungal, antibacterial, insecticidal and cytotoxic activity to the induction of neurite outgrowth in different cell assays. For this reason, this class of compounds has attracted much attention in the scientific community, resulting in the elucidation of the biosynthesis of some members which are formed by fungal polyketide synthases via tetramic acids by fungal polyketide synthases as well as different total synthesis approaches. This article will give a summary of the so far known structures, overview the different activities of the compounds and disclose the synthetic attempts since 1982.

1 March 2008 in Current Organic Chemistry
Verified
Journal Article
Closed access
KGKarl Gademann
Karl Gademann
CPCyril Portmann
Cyril Portmann
This review presents natural products from cyanobacteria. Several classes of secondary metabolites are highlighted. Toxic metabolites from these prokaryotic photosynthetic organisms include compounds such as microcystin, anatoxin and saxitoxin, which display hepatotoxicity and neurotoxicity. Their potential as drugs in cancer therapy is discussed based on the cryptophycin class of potent cytotoxic agents. The next part of this review highlights iron chelators from cyanobacteria, including schizokinen, synechobactin and anachelin. The biogenesis of anachelin is investigated as its mechanism of iron acquisition. Several indole alkaloids are then reviewed, from simple carbolines such as bauerines and nostocarboline to complex polycyclic structures such as hapalindole, welwitindolinone and ambiguine. The latter compounds present fascinating structure combined with powerful bioactivities and interesting biogenetic pathways. In the last part, protease inhibitors from cyanobacteria are discussed (cyanopeptolins, micropeptin and oscillapeptin) and their structure/ activity relationships and selectivity for trypsin / chymotrypsin are presented. All these examples highlight the large structural variety of cyanobacterial metabolites combined with powerful biological activities. Cyanobacteria can thus be considered a prime source both for novel bioactive compounds and for leads for drugs.

16 August 2002 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KGKarl Gademann
Karl Gademann
DCDavid E. Chavez
David E. Chavez
EJEric N. Jacobsen
Eric N. Jacobsen

16 February 2001 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
XDXavier Daura
Xavier Daura
KGKarl Gademann
Karl Gademann
HSHeiko Schäfer
Heiko Schäfer
BJBernhard Jaun
Bernhard Jaun
DSDieter Seebach
Dieter Seebach
WGWilfred F. van Gunsteren
Wilfred F. van Gunsteren